HK Stock MarketDetailed Quotes

08049 JILIN CHANGLONG

Watchlist
  • 1.450
  • +0.030+2.11%
Market Closed Nov 1 16:08 CST
812.36MMarket Cap4.32P/E (TTM)

About JILIN CHANGLONG Company

Jilin Huinan Changlong Biochemical Pharmaceutical Co., Ltd. is located at the foot of the beautiful and rich Changbai Mountain. Inside the Huinan Economic Development Zone Pharmaceutical Industrial Park in Tonghua, a famous pharmaceutical city in the country. The company was founded in 1989 and is a key enterprise in the pharmaceutical industry in Jilin Province. It was named “Excellent Enterprise” and “Outstanding Contribution Enterprise” by the provincial government. It was recognized as a high-tech enterprise by the Provincial Science and Technology Commission in 1999, and was the first modern pharmaceutical enterprise in Jilin Province to fully pass national GMP certification in 2000. In 2001, it was recognized by the Ministry of Science and Technology as a national key high-tech enterprise and a key enterprise in the biomedical industry base of the National Torch Program. The company's shares were listed in Hong Kong in the same year. Over the past 20 years, management has been strictly regulated in accordance with the “Company Law” and has developed into a medium-sized pharmaceutical enterprise with high efficiency, high growth, high technology content, integrating scientific research and development, production, operation, and marketing. The company is under wholly-owned companies such as Changlong Distribution Company, Changlong Linxia Ginseng Base, Changlong Hotel, and Changlong Real Estate Company. It currently has 520 employees, 238 varieties in 11 dosage forms, and 10 production workshops. The solid and injectable workshops all passed the new GMP certification at the end of 2014. The core product “Haikun Xinxi Capsule” has become a first-line product used in the field of treatment of renal failure in China. The company has provincial technology centers, quality evaluation centers, animal laboratories, process research laboratories, and pilot laboratories, which are mainly engaged in the application of technological achievements in new drug research, improvement and improvement of pharmaceutical processes, and in-depth development of existing drugs. Total assets have reached 700 million yuan. In order to meet the company's development needs, it moved to the Huinan Economic Development Zone Pharmaceutical Industrial Park in 2013, covering an area of 130,000 square meters. The company has always adhered to the business philosophy of “technology, innovation, good virtue and help the world”. Follow the path of globalization and contribute to the health of the world's people as an unremitting effort and pursuit of the company's development. Facing the opportunities and challenges of integrating the world economy, the Changlong people, with their own technological talent advantages, an innovative and realistic management team, and a modern enterprise system that is in line with the international community, stand on a new starting line for the development of modern medicine. With the grandeur and simplicity of Kanto people, the essence of Changbaishan's resources, and the spirit of agar-agar syrup from the world, Changlong Pharmaceutical is like a dragon taking off. It will definitely stand in the forest of Oriental Pharmaceuticals in the world and create a more brilliant tomorrow.

Company Profile

Symbol08049
Company NameJILIN CHANGLONG
ISINCNE100000130
Listing DateMay 24, 2001
Issue Price0.50
Shares Offered150.00M share(s)
FoundedAug 16, 1996
Registered AddressChina
Chairmanhong zhang
Secretaryshichang mo
Audit InstitutionShanghui Baicheng Certified Public Accountants Co., Ltd.
Company CategoryMainland registration of Mainland Individuals control
Registered Office31 Beishan street, Chaoyang town, Huinan country, Tonghua, Jilin province, china
Head Office and Principal Place of BusinessRoom 1101-02, 11th floor, Yalan Centre Office Tower II, 625 and 639 Nathan Road, Mongkok, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees678
MarketGEM
Phone(86)04358215333
Fax(86)04358210005
Emailcontactus@jlchanglong.com
Business The company's business mainly manufactures and distributes the Group's Changlong and Shendi brand biochemicals in China.

Company Executives

  • Name
  • Position
  • Salary
  • hong zhang
  • Presidencies, Executive Director, Remuneration Committee Members, Chief Inspector, Authorized Representative
  • 623.00K
  • xiaoguang zhang
  • Executive Director, General Manager, Nomination Committee Members
  • 478.00K
  • baogang zhao
  • Executive Director, Chief Financial Officer, Authorized Representative
  • 439.00K
  • guowen wu
  • Executive Director, Vice President of Sales
  • 182.00K
  • yi zhang
  • Executive Director, Managing Manager
  • 400.00K
  • xiangfu xu
  • Executive Director, Deputy General Manager of Production
  • 261.00K
  • qipin gao
  • Independent Non-Executive Director, Chairman of the Nomination Committee, Audit Committee Members, Remuneration Committee Members
  • 72.00K
  • jungui bai
  • Independent Non-Executive Director, Audit Committee Members, Remuneration Committee Members, Nomination Committee Members
  • 10.00K
  • jie tian
  • Independent Non-Executive Director, Remuneration Committee Members, Nomination Committee Members, Audit Committee Members
  • 10.00K
  • liyu yan
  • Auditors
  • --
  • xiaochun qiao
  • Auditors
  • --
  • yingxu wang
  • Auditors
  • --
  • shichang mo
  • Qualified Accountants, Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data